Suggestions
Gregory Rockson
Co-Founder and CEO at mPharma
Gregory Rockson is the Co-Founder and CEO of mPharma, a healthcare technology company that aims to improve access to medicines and healthcare services across Africa. Founded in 2014, mPharma operates in multiple countries, including Ghana, Nigeria, Zambia, Kenya, Uganda, Ethiopia, Togo, Gabon, Rwanda, and Malawi. The company focuses on transforming community pharmacies into primary healthcare providers through innovative solutions such as vendor-managed inventory services and data analytics.123
Background and Education
Gregory Rockson holds a Bachelor’s degree in Political Science from Westminster College and has furthered his education as a PPIA Fellow at Princeton University's Woodrow Wilson School and a Rotary Scholar at the University of Copenhagen. His diverse background includes founding initiatives like Big Brother Big Sister in Denmark and the Six Days of Peace Project aimed at fostering dialogue between Israeli and Palestinian diplomats.134
Professional Experience
- mPharma: As CEO since its inception, Rockson has led the company to become a significant player in the African healthcare sector, managing a network of over 500 pharmacies and providing essential healthcare services to millions.23
- Vine Pharmaceuticals: He serves as Executive Chairman of Vine Pharmaceuticals in Uganda, which was acquired by mPharma in 2021.1
- Haltons Limited: Rockson is also the Executive Chairman of Haltons Limited, a leading pharmacy chain in Kenya, further expanding mPharma's footprint across the continent.1
Achievements
Under Rockson's leadership, mPharma has raised substantial funding to support its mission and has been recognized for its innovative approach to healthcare delivery. In 2019, he received the Skoll Award for Social Entrepreneurship, highlighting his impact on improving healthcare access in Africa.34
Rockson's vision for mPharma includes leveraging technology to enhance patient care through tools that enable better communication between pharmacists and patients, thereby improving treatment adherence and health outcomes.23
Highlights
It is a failure of philanthropy and not a sign of success that in 2024, countries like Ghana, Nigeria or Kenya continue to receive donations of malaria bed nets, malaria medications or HIV test kits when corruption runs rampant and political cronies siphon funds.
One can argue that continuing to absolve African governments of their singular responsibility of using their resources for the betterment of their people because there will always be a new global health initiative to guilt Western countries and their taxpayers into donating money to solve these problems influences the vicious cycle of corruption in these countries.
If these governments are willing to let their people die of easily treatable and preventable diseases because they would instead steal from the people, then so be it. This may force their citizens to rise and demand better from their governments.
The world of philanthropy needs to take a step back and reflect on whether its objectives are driving fundamental systemic changes or simply creating the appearance of change by using "free money" to mask underlying socio-economic problems. This reflection is needed to discern whether philanthropic efforts are catalysts for genuine, enduring change or simply palliative measures that inadvertently slow the journey toward collective prosperity. Efosa Ojomo
